These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7047893)

  • 1. [Pancreatic beta cell function and the C-peptide content in the blood serum in thyrotoxicosis].
    Pavliuk PM; Slavnov VN; Epshteĭn EV
    Klin Med (Mosk); 1982 Apr; 60(4):51-4. PubMed ID: 7047893
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pancreatic beta-cell function in Itsenko-Cushing disease].
    Slavnov VN; Komissarenko IV; Eremenko NI
    Vrach Delo; 1983 Nov; (11):79-82. PubMed ID: 6362198
    [No Abstract]   [Full Text] [Related]  

  • 3. [Insulin and C-peptide in endogenous hypercorticism].
    Ametov AS; Kasatkin IuN; Larina IM
    Med Radiol (Mosk); 1980 Feb; 25(2):23-6. PubMed ID: 7360012
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dynamics of the glucagon and C-peptide content in Itsenko-Cushing disease].
    Arapova SD; Zavadskiĭ PS; Marova EI
    Sov Med; 1980; (2):42-7. PubMed ID: 6987746
    [No Abstract]   [Full Text] [Related]  

  • 5. [Beta cell activity in uremia. Determination of plasma insulin and C peptide after intravenous administration of glucose].
    Panzetta G; Mioni G; Cristinelli L; Broccoli R; Maiorca R; Valentini U; Rigosa C; Giustina G
    Minerva Nefrol; 1979; 26(3):339-42. PubMed ID: 400448
    [No Abstract]   [Full Text] [Related]  

  • 6. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity.
    Block MB; Rosenfield RL; Mako ME; Steiner DF; Rubenstein AH
    N Engl J Med; 1973 May; 288(22):1144-8. PubMed ID: 4633551
    [No Abstract]   [Full Text] [Related]  

  • 8. Secretory function of pancreatic beta cell during insulin-induced hypoglycemia evaluated by C-peptide immunoreactivity (CPR) determination.
    Shima K; Tanaka R; Morishita S; Sawazaki N; Ichihara K; Kumahara Y; Yanaihara N
    Med J Osaka Univ; 1978 Dec; 29(3-4):221-8. PubMed ID: 379559
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations on B-cell function after segmental pancreatic allotransplantation in diabetic patients.
    Gunnarsson R; Collste H; Lundgren G; Ostman J; Groth CG
    Horm Metab Res Suppl; 1983; (13):42-6. PubMed ID: 6345317
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of L-leucine and aminophylline tests in evaluation of the function of islands of Langerhans in patients with thyrotoxicosis].
    Zhurova TE; Tsiukhno ZI; Iurchenko MZ
    Ter Arkh; 1981; 53(10):111-4. PubMed ID: 7031954
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disorders of glucose tolerance in thyrotoxicosis].
    Zhurova TE
    Ter Arkh; 1981; 53(5):126-9. PubMed ID: 7027505
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of plasmatic C-peptide and its clinical uses].
    Cautela G; Barbero PL; Gamba S; Regis G; Bruni B
    Ann Osp Maria Vittoria Torino; 1978; 21(7-12):203-37. PubMed ID: 399164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-cell function assessed by plasma C-peptide evaluation in diabetic thalassaemic patients.
    Atti G; Capra L; De Sanctis V; Vullo C; Bagni B
    Helv Paediatr Acta; 1983 May; 38(2):123-32. PubMed ID: 6347976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic importance of the glucagon tolerance test in studying the islets of Langerhans apparatus of thyrotoxicosis patients].
    Zhurova TE
    Probl Endokrinol (Mosk); 1982; 28(2):21-6. PubMed ID: 7043446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endocrine function of the pancreas in patients with organic hyperinsulinism syndrome].
    Lifshits IuZ; Usenko AIu; Kozhara SP; Furmanenko ED
    Klin Khir; 1996; (5):10-1. PubMed ID: 8991669
    [No Abstract]   [Full Text] [Related]  

  • 16. Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders.
    Tura A; Pacini G; Kautzky-Willer A; Ludvik B; Prager R; Thomaseth K
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E155-62. PubMed ID: 12670835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism].
    Hanssen KF; Torjesen PA; Heding LG
    Tidsskr Nor Laegeforen; 1981 Dec; 101(34-36):1957-60. PubMed ID: 6280336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correlations between islet-pancreatic activity and blood pressure in obesity].
    Cerasola G; Verga S; Cottone S; Donatelli M; Vaccaro M; Contorno A; Bompiani G
    Cardiologia; 1988 Feb; 33(2):169-73. PubMed ID: 3282658
    [No Abstract]   [Full Text] [Related]  

  • 19. [C-peptide and insulin in diabetics].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):651-6. PubMed ID: 6819875
    [No Abstract]   [Full Text] [Related]  

  • 20. [Functional state of the islet apparatus in pancreatic cancer].
    Koroliuk IP; Gorbunov OM
    Khirurgiia (Mosk); 1980 Oct; (10):54-7. PubMed ID: 7001136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.